메뉴 건너뛰기




Volumn 109, Issue 37, 2012, Pages

Reply to Othy et al.: Dendritic cell-specific expression of CCR4 is required for development of EAE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; SOLVENT;

EID: 84866289004     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1209505109     Document Type: Letter
Times cited : (3)

References (6)
  • 1
    • 84866277908 scopus 로고    scopus 로고
    • Effect of CC chemokine receptor 4 antagonism on the evolution of experimental autoimmune encephalomyelitis
    • Othy S, Topçu S, Kaveri SV, Bayry J (2012) Effect of CC chemokine receptor 4 antagonism on the evolution of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 109:E2412-E2413.
    • (2012) Proc Natl Acad Sci USA , vol.109
    • Othy, S.1    Topçu, S.2    Kaveri, S.V.3    Bayry, J.4
  • 2
    • 84857938454 scopus 로고    scopus 로고
    • CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells
    • Poppensieker K, et al. (2012) CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells. Proc Natl Acad Sci USA 109:3897-3902.
    • (2012) Proc Natl Acad Sci USA , vol.109 , pp. 3897-3902
    • Poppensieker, K.1
  • 3
    • 40449111457 scopus 로고    scopus 로고
    • Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells
    • Lim HW, Lee J, Hillsamer P, Kim CH (2008) Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J Immunol 180(1):122-129.
    • (2008) J Immunol , vol.180 , Issue.1 , pp. 122-129
    • Lim, H.W.1    Lee, J.2    Hillsamer, P.3    Kim, C.H.4
  • 4
    • 75749133624 scopus 로고    scopus 로고
    • Immune cell entry to central nervous system - Current understanding and prospective therapeutic targets
    • Prendergast CT, Anderton SM (2009) Immune cell entry to central nervous system - Current understanding and prospective therapeutic targets. Endocr Metab Immune Disord Drug Targets 9:315-327.
    • (2009) Endocr Metab Immune Disord Drug Targets , vol.9 , pp. 315-327
    • Prendergast, C.T.1    Anderton, S.M.2
  • 5
    • 70449525704 scopus 로고    scopus 로고
    • Chemokines and chemokine receptors: Standing at the crossroads of immunobiology and neurobiology
    • Ransohoff RM (2009) Chemokines and chemokine receptors: Standing at the crossroads of immunobiology and neurobiology. Immunity 31:711-721.
    • (2009) Immunity , vol.31 , pp. 711-721
    • Ransohoff, R.M.1
  • 6
    • 33846303121 scopus 로고    scopus 로고
    • Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents
    • Rosenberg GA, Estrada EY, Mobashery S (2007) Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents. Brain Res 1133(1):186-192.
    • (2007) Brain Res , vol.1133 , Issue.1 , pp. 186-192
    • Rosenberg, G.A.1    Estrada, E.Y.2    Mobashery, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.